These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy. Bahn RS J Endocrinol Invest; 2004 Mar; 27(3):216-20. PubMed ID: 15164996 [TBL] [Abstract][Full Text] [Related]
64. [Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy]. Bossowski A; Stasiak-Barmuta A; Urban M; Rinderle C Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):93-101. PubMed ID: 15504312 [TBL] [Abstract][Full Text] [Related]
65. The interaction of MHC and Gm in liability to autoimmune thyroid disease. Nagataki S Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922 [TBL] [Abstract][Full Text] [Related]
66. The role of TSH receptor antibodies in the management of Graves' disease. Matthews DC; Syed AA Eur J Intern Med; 2011 Jun; 22(3):213-6. PubMed ID: 21570635 [TBL] [Abstract][Full Text] [Related]
67. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization. Wu SL; Yang CS; Wang HJ; Liao CL; Chang TJ; Chang TC J Endocrinol Invest; 1999 Apr; 22(4):289-95. PubMed ID: 10342363 [TBL] [Abstract][Full Text] [Related]
68. Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor. Okamoto Y; Yanagawa T; Fisfalen ME; DeGroot LJ Thyroid; 1994; 4(1):37-42. PubMed ID: 7519915 [TBL] [Abstract][Full Text] [Related]
69. Genotypes in relation to phenotypic appearance and exposure to environmental factors in Graves' hyperthyroidism. Vos XG; Endert E; Tijssen JG; Wiersinga WM Eur J Endocrinol; 2012 Dec; 167(6):783-92. PubMed ID: 22968483 [TBL] [Abstract][Full Text] [Related]
70. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987 [TBL] [Abstract][Full Text] [Related]
71. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Hodge SE; Ban Y; Strug LJ; Greenberg DA; Davies TF; Concepcion ES; Villanueva R; Tomer Y Thyroid; 2006 Apr; 16(4):351-5. PubMed ID: 16646680 [TBL] [Abstract][Full Text] [Related]
72. Association of single nucleotide polymorphism in CD28(C/T-I3 + 17) and CD40 (C/T-1) genes with the Graves' disease. Mustafa S; Fatima H; Fatima S; Khosa T; Akbar A; Shaikh RS; Iqbal F J Pak Med Assoc; 2018 Jan; 68(1):3-9. PubMed ID: 29371709 [TBL] [Abstract][Full Text] [Related]
73. Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease. Struja T; Kutz A; Fischli S; Meier C; Mueller B; Recher M; Schuetz P BMC Med; 2017 Sep; 15(1):174. PubMed ID: 28942732 [TBL] [Abstract][Full Text] [Related]
74. Graves' ophthalmopathy: pathogenesis and clinical implications. Major BJ; Busuttil BE; Frauman AG Aust N Z J Med; 1998 Feb; 28(1):39-45. PubMed ID: 9544385 [No Abstract] [Full Text] [Related]